I am going to start with the negatives. Over a few weeks ago, SI said a few weeks. Last year it was a momentous few months. Let’s just say that June is perhaps the code for September where Novartis are concerned, April 22 for SRGvHD. The batch consistency was brought up by the FDA guy at that recent conference but we are confident there. I believe our manufacturing process is an Ace card. Us long term investors are going to have to renew the patience ticket and the floor is clear for the traders and shorters to have a crack in the next several weeks. The data not the date is the recurring lesson for me.
Conclusion, no more waiting up for the ASX breakthrough announcement. I will check back closer to September. Will keep the occasional eye on HC as many of you have the ability to lift my spirits and make me laugh (thank you). Others? May have to update the ignore list. I am going to enjoy my summer.
Take care
Yelrom
Ann: Mesoblast Q3 Financial Results Webcast, page-121
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.010(0.91%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.11 | $1.07 | $4.794M | 4.399M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14500 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 141676 | 5 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |